Sobre el 70% de los casos se produce después de un procedimiento dental Palabras clave: osteonecrosis, bifosfonatos, osteonecrosis de los maxilares. os riscos das condições orais e sistêmicas que envolvem o uso de bifosfonatos. para tratar a estos pacientes en las distintas especialidades odontologicas. La prevalencia de avulsión dental supone del 0, % de todas las lesiones .. (58), acetazolamida (59), bifosfonatos (60,61)o derivado de la matriz del.

Author: Teshura Arashitaxe
Country: Austria
Language: English (Spanish)
Genre: Video
Published (Last): 8 March 2016
Pages: 394
PDF File Size: 18.60 Mb
ePub File Size: 9.21 Mb
ISBN: 835-2-77419-929-1
Downloads: 91854
Price: Free* [*Free Regsitration Required]
Uploader: Tuzilkree

Bisphosphonate therapy odonttologia the outcome of conventional periodontal treatment: Rev Osteoporos Metab Miner ; 1 1: Sociedad de Periodoncia de Chile. J Periodontol, 76pp. The purpose of this review is to describe the characteristics of bisphosphonates, its mechanism of action, clinical manifestation of osteonecrosis of the jaws, therapeutic management and prevention.

N Engl J Med ; Treatment of osteoporosis with biphosphonates. Novel antiogenic effects of the bisphosphonate compound Zoledronic acid. Posible association between diabetes and bisphosphonate-related jaw osteonecrosis.


J Orthop Sci, 12pp. Clin Endocrinol Oxf ; 72 2: Thirteen cases of jaw osteonecrosis in patients on bisphosphonate therapy. Bisphosphanates and oral cavity avascular bone necrosis.

Osteoporos Int ; 20 8: Inhibition of bone resorption by alendronate and risedronate does not require osteoclast apoptosis. Endocr Rev ; Treatment of hypercalcemia of malignancy with biphosphonates. Nitrogen-containing bisphosphonates inhibit the Mevalonate pathway and prevent post-translational prenylation of GTP-binding proteins, including Ras.

An emerging pattern of subtrochanteric stress fractures: Is bisphosphonate-associated osteonecrosis of the jaw caused by soft tissue toxicity? Osteonecrosis of the jaw.

Osteonecrosis de los Maxilares Asociado a Terapia con Bifosfonatos: Situación Actual

Odontolofia biphosphonate therapy in children with osteogenesis imperfecta. Se han propuesto algunas recomendaciones para el manejo de los pacientes tratados con bifosfonatos que presentan efectos adversos oculares Tabla II.

Osteoporos Int ; 20 Esophagitis associated with the use of alendronate. A, Holgado S, Costa J.

Biphosphonates and fractures of the subtrochanteric or diaphyseal femur. Ann Intern Med ; Probably the origin of the osteonecrosis of the jaws is a decreased microcirculation and a limited bone turnover due to bisphosphonates, leading to diminish their healing capacity and regeneration of the tissues.


J Orthop Trauma ; 22 5: Low-energy femoral shaft fractures associated with alendronate use. Palliative treatment is proposed with oral rinses and systemic antibiotic therapy. Retina ; 28 6: Scleritis and other ocular side effects associated with pami-dronate disodium.

Macarol V, Fraunfelder FT. Otros estudio, que utilizaba la misma base de datos que el de Green y cols. J Oral Maxillofac Surg, 63pp. In this group of selected patients with recurrent lithiasis and osteopenia the bifosfobatos with biphosphonates alone or associated with thiazide diuretics has given good results in renal lithiasis control and bone demineralization.

Tratamiento de la litiasis renal con bifosfonatos

A review of 63 cases. Bisphosphonate-associated bifpsfonatos of the jaw: J Buon ; J Clin Oncol, 23pp. Los bisfosfonatos y las fracturas por fatiga.